- Home
- ETON vs WNEB Comparison
ETON vs WNEB Comparison
Compare ETON & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- WNEB
- Stock Information
- Founded
- ETON 2017
- WNEB 1853
- Country
- ETON United States
- WNEB United States
- Employees
- ETON N/A
- WNEB N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- WNEB Savings Institutions
- Sector
- ETON Health Care
- WNEB Finance
- Exchange
- ETON Nasdaq
- WNEB Nasdaq
- Market Cap
- ETON 199.5M
- WNEB 196.7M
- IPO Year
- ETON 2018
- WNEB N/A
- Fundamental
- Price
- ETON $11.91
- WNEB $9.67
- Analyst Decision
- ETON Strong Buy
- WNEB Hold
- Analyst Count
- ETON 2
- WNEB 3
- Target Price
- ETON $15.00
- WNEB $8.50
- AVG Volume (30 Days)
- ETON 236.0K
- WNEB 51.3K
- Earning Date
- ETON 11-12-2024
- WNEB 01-21-2025
- Dividend Yield
- ETON N/A
- WNEB 2.87%
- EPS Growth
- ETON N/A
- WNEB N/A
- EPS
- ETON N/A
- WNEB 0.52
- Revenue
- ETON $34,677,000.00
- WNEB $72,500,000.00
- Revenue This Year
- ETON $23.05
- WNEB N/A
- Revenue Next Year
- ETON $81.27
- WNEB $6.24
- P/E Ratio
- ETON N/A
- WNEB $18.89
- Revenue Growth
- ETON 5.64
- WNEB N/A
- 52 Week Low
- ETON $3.03
- WNEB $6.00
- 52 Week High
- ETON $13.98
- WNEB $10.08
- Technical
- Relative Strength Index (RSI)
- ETON 54.63
- WNEB 68.93
- Support Level
- ETON $11.64
- WNEB $9.76
- Resistance Level
- ETON $13.01
- WNEB $10.08
- Average True Range (ATR)
- ETON 0.82
- WNEB 0.19
- MACD
- ETON -0.16
- WNEB 0.03
- Stochastic Oscillator
- ETON 11.54
- WNEB 77.27
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the Company's revenues, profits, and assets are derived by the Bank from banking products and services.